Full Text View
Tabular View
No Study Results Posted
Related Studies
A Study to Evaluate Efficacy and Safety Effects Using Mikelan® LA Ophthalmic Solution (OS) 2% Versus Timoptol® XE Ophthalmic Solution (OS) 0.5% in Ocular Hypertension Patients
This study has been completed.
Study NCT00972426   Information provided by Taiwan Otsuka Pharm. Co., Ltd

First Received on August 20, 2009.   Last Updated on September 1, 2011   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Additional conditions recognized in this trial
More general conditions related to this trial
Additional drug interventions recognized in this trial
More general drug interventions related to this trial
Sponsors listed in this trial